AR049846A1 - Preparaciones farmaceuticas de derivados de la piperazina - Google Patents
Preparaciones farmaceuticas de derivados de la piperazinaInfo
- Publication number
- AR049846A1 AR049846A1 ARP050102897A ARP050102897A AR049846A1 AR 049846 A1 AR049846 A1 AR 049846A1 AR P050102897 A ARP050102897 A AR P050102897A AR P050102897 A ARP050102897 A AR P050102897A AR 049846 A1 AR049846 A1 AR 049846A1
- Authority
- AR
- Argentina
- Prior art keywords
- preservative
- pharmaceutical preparations
- piperazine derivatives
- preservatives
- less
- Prior art date
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical class C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 title 1
- 229940066771 systemic antihistamines piperazine derivative Drugs 0.000 title 1
- 239000003755 preservative agent Substances 0.000 abstract 4
- 230000002335 preservative effect Effects 0.000 abstract 3
- FJKROLUGYXJWQN-UHFFFAOYSA-M 4-hydroxybenzoate Chemical class OC1=CC=C(C([O-])=O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-M 0.000 abstract 2
- 239000007788 liquid Substances 0.000 abstract 2
- ZKLPARSLTMPFCP-OAQYLSRUSA-N 2-[2-[4-[(R)-(4-chlorophenyl)-phenylmethyl]-1-piperazinyl]ethoxy]acetic acid Chemical compound C1CN(CCOCC(=O)O)CCN1[C@@H](C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-OAQYLSRUSA-N 0.000 abstract 1
- BAWMMJAUVBLLEE-UHFFFAOYSA-N 2-[2-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]ethoxy]acetic acid Chemical compound C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(F)=CC=1)C1=CC=C(F)C=C1 BAWMMJAUVBLLEE-UHFFFAOYSA-N 0.000 abstract 1
- ZKLPARSLTMPFCP-UHFFFAOYSA-N Cetirizine Chemical compound C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 229960001803 cetirizine Drugs 0.000 abstract 1
- 150000008640 diphenylmethylpiperazines Chemical group 0.000 abstract 1
- 229950003420 efletirizine Drugs 0.000 abstract 1
- 229960001508 levocetirizine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Otolaryngology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Preparacion líquida que contiene un principio activo perteneciente a la familia de las benzhidril piperazinas sustituidas con cantidades reducidas de conservantes. Reivindicacion 1: Una preparacion farmacéutica líquida que contiene un principio activo elegido entre cetirizina, levocetirizina y efletirizina, y al menos un conservante, donde la cantidad de conservante es en el caso de los ésteres de parahidroxibenzoato superior a 0 e inferior a 1,5 mg/ml de la preparacion, y en el caso de otros conservantes es tal que produce los mismos efectos conservantes que una concentracion de ésteres de parahidroxibenzoato superior a 0 e inferior a 1,5 mg/ml.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04016519 | 2004-07-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR049846A1 true AR049846A1 (es) | 2006-09-06 |
Family
ID=34925743
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050102897A AR049846A1 (es) | 2004-07-14 | 2005-07-13 | Preparaciones farmaceuticas de derivados de la piperazina |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US8633194B2 (es) |
| EP (1) | EP1768649B1 (es) |
| JP (1) | JP4902875B2 (es) |
| KR (1) | KR101185612B1 (es) |
| CN (1) | CN100508981C (es) |
| AR (1) | AR049846A1 (es) |
| AT (1) | ATE443512T1 (es) |
| AU (1) | AU2005261953B2 (es) |
| BR (1) | BRPI0513257C1 (es) |
| CA (1) | CA2573662A1 (es) |
| CY (1) | CY1109670T1 (es) |
| DE (1) | DE602005016802D1 (es) |
| EA (1) | EA012463B1 (es) |
| ES (1) | ES2332462T3 (es) |
| IL (1) | IL180010A0 (es) |
| MX (1) | MX2007000230A (es) |
| MY (1) | MY149403A (es) |
| NO (1) | NO337768B1 (es) |
| NZ (1) | NZ552182A (es) |
| PE (1) | PE20060484A1 (es) |
| PL (1) | PL1768649T3 (es) |
| PT (1) | PT1768649E (es) |
| TW (1) | TWI304339B (es) |
| WO (1) | WO2006005507A2 (es) |
| ZA (1) | ZA200700939B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3943069T (pt) | 2009-03-17 | 2025-02-21 | Nicox Ophthalmics Inc | Formulações oftálmicas de cetirizina e métodos de utilização |
| US8569273B2 (en) | 2009-03-17 | 2013-10-29 | Aciex Therapeutics, Inc. | Ophthalmic formulations of cetirizine and methods of use |
| TWI503122B (zh) * | 2012-02-15 | 2015-10-11 | Taiho Pharmaceutical Co Ltd | Oral administration of pharmaceutical compositions |
| KR102155836B1 (ko) | 2013-02-22 | 2020-09-14 | 삼성전자주식회사 | 터치 스크린 상에서 객체 디스플레이를 제어하는 휴대 단말 및 방법 |
| US11241426B2 (en) * | 2017-02-13 | 2022-02-08 | Nitto Medic Co., Ltd. | Aqueous composition for ophthalmic or nasal administration |
| CN113712907A (zh) * | 2020-05-25 | 2021-11-30 | 南京帝昌医药科技有限公司 | 一种盐酸左西替利嗪滴眼液组合物及其制备方法 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4255358A (en) * | 1978-03-13 | 1981-03-10 | The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland | Process for the production of hexanitrostilbene |
| FI75816C (fi) | 1981-02-06 | 1988-08-08 | Ucb Sa | Foerfarande foer framstaellning av terapeutiskt aktiv 2-/4-(difenylmetyl)-1-piperazinyl/-aettiksyror eller dess amid. |
| NZ215069A (en) | 1985-03-01 | 1988-06-30 | Reckitt & Colmann Prod Ltd | Pharmaceutical composition with histamine h 2 -receptor antagonist |
| US4728509A (en) | 1985-08-19 | 1988-03-01 | Takeda Chemical Industries, Ltd. | Aqueous liquid preparation |
| JP3278192B2 (ja) | 1992-04-03 | 2002-04-30 | ロート製薬株式会社 | 徐放性液剤 |
| TW401300B (en) | 1992-12-25 | 2000-08-11 | Senju Pharma Co | Antiallergic composition for ophthalmic or nasal use |
| US5504113A (en) | 1994-03-02 | 1996-04-02 | Allergan, Inc. | Enhancement of benzalkonium chloride preservative activity in formulations containing an incompatible drug |
| AU3609795A (en) | 1994-10-10 | 1996-05-02 | Novartis Ag | Ophthalmic and aural compositions containing diclofenac potassium |
| TW536403B (en) | 1997-03-24 | 2003-06-11 | Glaxo Group Ltd | An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy |
| US6432961B1 (en) | 1998-08-18 | 2002-08-13 | Ucb S.A. | Method for preventing the onset of asthma |
| AUPQ419099A0 (en) | 1999-11-23 | 1999-12-16 | Ko, Thomas Sai Ying | Novel compositions and methods |
| DE10007203A1 (de) | 2000-02-17 | 2001-08-23 | Asta Medica Ag | Neue Kombination nichtsedierender Antihistaminika mit Substanzen, die die Leukotrienwirkung beeinflussen, zur Behandlung der Rhinitis/Konjunktivitis |
| US6258814B1 (en) | 2000-10-13 | 2001-07-10 | Schering Corporation | Method of using cetirizine and pharmaceutical compositions containing the same for inducing sleep |
| UA80393C2 (uk) * | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
| WO2002047689A2 (en) | 2000-12-15 | 2002-06-20 | Ucb, S.A. | Use of cetirizine or efletirizine for preventing urticaria |
| US6869618B2 (en) | 2001-04-10 | 2005-03-22 | Kiel Laboratories, Inc. | Process for preparing tannate liquid and semi-solid dosage forms |
| KR101255356B1 (ko) | 2002-06-12 | 2013-04-17 | 케모센트릭스, 인크. | 염증 및 면역 질병의 치료를 위한 ｃｃｒ１ 길항물질로서사용하기 위한 1-아릴-4-치환된 피페라진 유도체 |
| AU2003251152A1 (en) | 2002-07-03 | 2004-01-23 | Shannon Biotechnology Ltd | Pharmaceutical formulations for preparing drink products |
| PL377470A1 (pl) | 2002-12-03 | 2006-02-06 | Ucb Farchim S.A. | Zastosowanie lewocetyryzyny do leczenia przetrwałego alergicznego nieżytu nosa |
| US20050255154A1 (en) | 2004-05-11 | 2005-11-17 | Lena Pereswetoff-Morath | Method and composition for treating rhinitis |
| US20090137645A1 (en) | 2007-10-31 | 2009-05-28 | Midlothian Laboratories, Llc | Shelf-Stable Famotidine Granulates for Oral Suspensions |
-
2005
- 2005-07-04 PE PE2005000777A patent/PE20060484A1/es not_active Application Discontinuation
- 2005-07-06 TW TW094122831A patent/TWI304339B/zh not_active IP Right Cessation
- 2005-07-06 US US10/599,451 patent/US8633194B2/en active Active
- 2005-07-07 ES ES05758582T patent/ES2332462T3/es not_active Expired - Lifetime
- 2005-07-07 AT AT05758582T patent/ATE443512T1/de active
- 2005-07-07 CA CA002573662A patent/CA2573662A1/en not_active Abandoned
- 2005-07-07 ZA ZA200700939A patent/ZA200700939B/xx unknown
- 2005-07-07 KR KR1020077003545A patent/KR101185612B1/ko not_active Expired - Lifetime
- 2005-07-07 WO PCT/EP2005/007340 patent/WO2006005507A2/en not_active Ceased
- 2005-07-07 CN CNB2005800234732A patent/CN100508981C/zh not_active Ceased
- 2005-07-07 EA EA200700067A patent/EA012463B1/ru not_active IP Right Cessation
- 2005-07-07 BR BRPI0513257A patent/BRPI0513257C1/pt active IP Right Grant
- 2005-07-07 MY MYPI20053111A patent/MY149403A/en unknown
- 2005-07-07 JP JP2007520716A patent/JP4902875B2/ja not_active Expired - Lifetime
- 2005-07-07 PT PT05758582T patent/PT1768649E/pt unknown
- 2005-07-07 PL PL05758582T patent/PL1768649T3/pl unknown
- 2005-07-07 EP EP05758582A patent/EP1768649B1/en not_active Revoked
- 2005-07-07 AU AU2005261953A patent/AU2005261953B2/en not_active Expired
- 2005-07-07 NZ NZ552182A patent/NZ552182A/en not_active IP Right Cessation
- 2005-07-07 DE DE602005016802T patent/DE602005016802D1/de not_active Expired - Lifetime
- 2005-07-07 MX MX2007000230A patent/MX2007000230A/es active IP Right Grant
- 2005-07-13 AR ARP050102897A patent/AR049846A1/es not_active Application Discontinuation
-
2006
- 2006-12-12 IL IL180010A patent/IL180010A0/en unknown
-
2007
- 2007-02-13 NO NO20070832A patent/NO337768B1/no unknown
-
2009
- 2009-11-25 CY CY20091101233T patent/CY1109670T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2169087T3 (es) | Formulaciones orales de un antifungico. | |
| EP1243524A3 (en) | Pharmaceutical kit for oxygen-sensitive drugs | |
| PE20050438A1 (es) | Formulas farmaceuticas, metodos y regimenes de dosificacion para el tratamiento y la prevencion de sindromes coronarios agudos | |
| DE60312523D1 (de) | Orale, pharmazeutische darreichungsformen von flüssigen medikamenten mitverbesserter bioverfügbarkeit | |
| SE0003449L (sv) | Cancerhämmande kompositioner | |
| UA102478C2 (en) | Capsule composition | |
| EA200601253A1 (ru) | Преимущественно линейная шипучая лекарственная форма фентанила для перорального применения и способы введения | |
| NO20080220L (no) | Formuleringer med hoy medikament belastning og doseringsformer | |
| WO2005110398A3 (en) | Pharmaceutical solution formulations containing 17-aag | |
| AR034370A1 (es) | Una preparacion farmaceutica acuosa de cilostazol para uso parenteral | |
| BRPI0311189B8 (pt) | composições farmacêuticas contendo polimorfo a de flibanserin, bem como seu uso | |
| IT1263840B (it) | Formulazioni orali di ubidecarenone in forma di capsule | |
| EA200601901A1 (ru) | Композиции, содержащие иммуномодулирующие соединения для лечения и управления течением миелодиспластических синдромов и способы с их использованием | |
| ECSP044979A (es) | Uso de bibn4096 en combinación con otros fármacos antimigrañosos para el tratamiento de migraña | |
| AR049846A1 (es) | Preparaciones farmaceuticas de derivados de la piperazina | |
| PT1414467E (pt) | Tratamento topico da mastalgia | |
| ATE400256T1 (de) | Pharmazeutische zusammensetzung mit einem kationischen hilfsmittel | |
| AR042598A1 (es) | Composiciones de acetaminofeno | |
| ES2197781A1 (es) | Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno. | |
| BRPI0511387A (pt) | composição e seu uso | |
| SE0303135D0 (sv) | Controlled food effect composition | |
| EA200601015A1 (ru) | Пероральные композиции дезоксипеганина и их применение | |
| BR0214487A (pt) | Composição farmacêutica que compreende uma combinação de metformina e um ácido 4-oxobutanóico, e o uso da mesma para o tratamento de diabetes | |
| AR044939A1 (es) | Sistema de administracion para medicaciones topicas | |
| TW200611697A (en) | Generally linear effervescent oral fentanyl dosage form and methods of administering |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |